Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype.
Ganna Chornokur(Moffitt Cancer Center), Catherine M. Phelan(University of Southern California), Ellen L. Goode(Mayo Clinic in Arizona), Thomas A. Sellers(Mayo Clinic), Hui‐Yi Lin(Moffitt Cancer Center), Simon A. Gayther(The University of Texas Health Science Center at Houston), Ya-Yu Tsai(Moffitt Cancer Center), Susan J. Ramus(Cancer Institute of New South Wales), Andrew Berchuk(Duke University), Joellen M. Schildkraut(Duke University Hospital), Álvaro N.A. Monteiro(Moffitt Cancer Center), Gang Han(Texas A&M Health Science Center), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Steven A. Narod(Women's College Hospital), Edwin S. Iversen, Julie M. Cunningham(Cancer Research UK), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jonathan P. Tyrer(University of Cambridge)
Cited by 0
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k